Loading…
Loading…
So making adjustments there, it looks like quite a slowdown
Can we dig a little more maybe on the consumer and CPG, particularly in the U.S. and Europe
Can you maybe just talk about the operating leverage across the P&L given how much has changed so far
since John and James your arrival, it's been about dollar based growth and worked very hard to be able to grow earnings in dollar terms
can you maybe just talk about how you think about cash or capital allocation when you're on the other side of it
is this within the salty-snack aisle, or with the incremental shelf space, maybe in other parts of the store
To what degree are you open to the idea of franchising some of these operations on the beverage side
that was quite the tease on the big launch in protein. There is anything you could add
what do you think about the launch of GLP-1 oral medications coming to market next year
I just wonder if these restructurings are maybe a prelude to something bigger down the road or maybe what's your appetite for that
to the extent that you're able to calculate what actual usage is in the households, has that sort of trended off
Was there anything onetime in there as it relates to sort of a near-term benefit from flipping
is there a bit of a philosophical pivot or shift in any way that would be related to the timing of this
is it slowing your, you know, the pace of innovation rollouts or expectations from contribution of those innovations
if we can maybe dig in a little bit more on consumer health or healthcare, it's -- the comp was a bit easier